Lisa Chesney, the British high commissioner to Uganda, formally presented the award of Officer of the Most Excellent Order of ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The agency will require manufacturers to conduct randomized, controlled trials to secure approval for healthy Americans.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...

COVID vaccines are only approved for elderly and a few others as RFK continues to reshape how Americans fight disease - ...